Literature DB >> 8087864

Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation.

G P Bauman1, M M Bartik, W H Brooks, T L Roszman.   

Abstract

Recently, we have shown that T cells exposed to concentrations of prostaglandin E2 (PGE2) or the beta-adrenergic receptor agonist isoproterenol (ISO) that elicit equimolar levels of cAMP accumulation do not inhibit anti-CD3 monoclonal antibody-induced T cell proliferation to the same extent. This report extends these studies by investigating the induction of cAMP-dependent protein kinase (PKA) in T cells stimulated with PGE2 or ISO. The kinetics of PKA activity induced by PGE2 or ISO in T cells are similar but PGE2 induces more PKA activity. When T cells were treated with concentrations of PGE2 or ISO that elicited similar PKA activities, PGE2 was found to be more immunosuppressive than ISO. T cells stimulated with PGE2 or ISO showed similar levels of increased PKA activity in both the cytosolic and the particulate fractions. Quantitation of the activity of PKA I and PKA II isozymes in T cells stimulated with PGE2 or ISO revealed that both types were activated; however, while PGE2 induced the utilization of an equal amount of both isozymes in T cells, ISO-treated cells utilized twice as much PKA I compared to PKA II. Overall, these results suggest that qualitative differences in the concentration of cAMP and PKA activity are important elements in modulatory T cell proliferative responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087864     DOI: 10.1006/cimm.1994.1266

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

2.  Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.

Authors:  Matthew J Loza; Susan Foster; Stephen P Peters; Raymond B Penn
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

Review 3.  The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1996-09       Impact factor: 6.968

4.  Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells.

Authors:  N Kvirkvelia; I Vojnovic; T D Warner; V Athie-Morales; P Free; N Rayment; B M Chain; T W Rademacher; T Lund; I M Roitt; P J Delves
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

Review 5.  EPAC proteins transduce diverse cellular actions of cAMP.

Authors:  Gillian Borland; Brian O Smith; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

6.  Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis.

Authors:  M A Choudhry; S Ahmad; M M Sayeed
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 7.  Regulation of T cells in airway disease by beta-agonist.

Authors:  Matthew J Loza; Raymond B Penn
Journal:  Front Biosci (Schol Ed)       Date:  2010-06-01

Review 8.  Prostaglandin E2 and T cells: friends or foes?

Authors:  Vinatha Sreeramkumar; Manuel Fresno; Natalia Cuesta
Journal:  Immunol Cell Biol       Date:  2011-09-27       Impact factor: 5.126

9.  Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis.

Authors:  Matthias Wahle; Gesine Hanefeld; Stephan Brunn; Rainer H Straub; Ulf Wagner; Andreas Krause; Holm Häntzschel; Christoph G O Baerwald
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells.

Authors:  Michelle L McCully; Paul J Collins; Timothy R Hughes; Christopher P Thomas; Jaak Billen; Valerie B O'Donnell; Bernhard Moser
Journal:  J Immunol       Date:  2015-05-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.